Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis

NCT06811012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Bone
Joint

Interventions

DRUG: Contezolid
DRUG: Linezolid (LZD)

Sponsor

Beijing Chest Hospital